BioRestorative Therapies, Inc.
BRTX
$0.19
-$0.01-3.39%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.21M | -3.04M | -2.66M | -5.34M | -1.64M |
| Total Depreciation and Amortization | 52.80K | 52.60K | 52.70K | 51.80K | 50.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -155.80K | -271.50K | -179.60K | 2.54M | -850.70K |
| Change in Net Operating Assets | 895.40K | 356.00K | 89.30K | -31.20K | 88.60K |
| Cash from Operations | -2.42M | -2.90M | -2.69M | -2.78M | -2.35M |
| Capital Expenditure | -79.70K | 0.00 | 0.00 | -36.40K | -12.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.48M | 2.00M | 2.13M | 2.40M | 1.55M |
| Cash from Investing | 2.40M | 2.00M | 2.13M | 2.37M | 1.53M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -178.00K | 72.80K | -5.60K | -33.60K | -- |
| Issuance of Common Stock | 1.08M | 0.00 | 1.90M | 2.21M | 595.40K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -143.10K | -171.40K | -115.20K | 42.40K | -721.70K |
| Cash from Financing | 923.20K | -49.30K | 888.10K | 1.09M | -126.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 908.70K | -952.80K | 326.50K | 680.90K | -941.60K |